Global Research Trends on Nanotechnology and Colorectal Cancer: a Two-decade Analysis

Overview

Journal Nanomedicine (Lond)

Date 2025 Jan 20

PMID 39829306

Authors

Xinyu Mao

Xinhao Li

Shiwei Liu

Hui Dong

Weilu Jia

Wenjing Xu

Xia Wu

Yewei Zhang

Affiliations

Soon will be listed here.

Abstract

Introduction: Colorectal cancer (CRC) remains a serious threat to humans worldwide. In this study, we used bibliometric analysis of the scientific literature to assess the trends and prospects of nanotechnology applications in CRC.

Materials And Methods: We used the Web of Science Core Collection database to screen relevant publications on nanotechnology and CRC from 2004 to 2023 based on the inclusion criteria. Bibliometric analyses were performed on all selected publication and citation data. Visual analysis using VOSviewer and CiteSpace intuitively reflected the hotspots in this field.

Results: In total, 2040 publications on nanotechnology in CRC were identified for this two-decade analysis. China (443, 29.14%) and the USA (199, 13.09%) were the top two most productive countries, and Sichuan University was the most prolific institution. The most influential journal was the International Journal of Nanomedicine. The author with the most papers was Li L. "Nanoparticles," "drug delivery," and "CRC" were the most common keywords. Green synthesis and gold nanoparticles were peripheral, incompletely developed topics.

Conclusion: This study provides a comprehensive overview of nanomaterials in CRC as clinical medicine, enriching the body of evidence in this field.

References

Wu D, Zhu L, Li Y, Wang H, Xu S, Zhang X . Superparamagnetic chitosan nanocomplexes for colorectal tumor-targeted delivery of irinotecan. Int J Pharm. 2020; 584:119394. DOI: 10.1016/j.ijpharm.2020.119394. View

Mao Q, Min J, Zeng R, Liu H, Li H, Zhang C . Self-assembled traditional Chinese nanomedicine modulating tumor immunosuppressive microenvironment for colorectal cancer immunotherapy. Theranostics. 2022; 12(14):6088-6105. PMC: 9475452. DOI: 10.7150/thno.72509. View

Spaander M, Zauber A, Syngal S, Blaser M, Sung J, You Y . Young-onset colorectal cancer. Nat Rev Dis Primers. 2023; 9(1):21. PMC: 10589420. DOI: 10.1038/s41572-023-00432-7. View

Fu L, Wan Y, Qi C, He J, Li C, Yang C . Nanocatalytic Theranostics with Glutathione Depletion and Enhanced Reactive Oxygen Species Generation for Efficient Cancer Therapy. Adv Mater. 2021; 33(7):e2006892. DOI: 10.1002/adma.202006892. View

Wong S, Yu J . Gut microbiota in colorectal cancer: mechanisms of action and clinical applications. Nat Rev Gastroenterol Hepatol. 2019; 16(11):690-704. DOI: 10.1038/s41575-019-0209-8. View

Cheng Z, Li M, Dey R, Chen Y . Nanomaterials for cancer therapy: current progress and perspectives. J Hematol Oncol. 2021; 14(1):85. PMC: 8165984. DOI: 10.1186/s13045-021-01096-0. View

Liang P, Zheng J, Dai S, Wang J, Zhang Z, Kang T . pH triggered re-assembly of nanosphere to nanofiber: The role of peptide conformational change for enhanced cancer therapy. J Control Release. 2017; 260:22-31. DOI: 10.1016/j.jconrel.2017.05.018. View

Yang L, Zhu Y, Liang L, Wang C, Ning X, Feng X . Self-Assembly of Intelligent Nanoplatform for Endogenous HS-Triggered Multimodal Cascade Therapy of Colon Cancer. Nano Lett. 2022; 22(10):4207-4214. DOI: 10.1021/acs.nanolett.2c01131. View

. The rise and rise of graphene. Nat Nanotechnol. 2010; 5(11):755. DOI: 10.1038/nnano.2010.224. View

10.

Hamaguchi T, Matsumura Y, Suzuki M, Shimizu K, Goda R, Nakamura I . NK105, a paclitaxel-incorporating micellar nanoparticle formulation, can extend in vivo antitumour activity and reduce the neurotoxicity of paclitaxel. Br J Cancer. 2005; 92(7):1240-6. PMC: 2361981. DOI: 10.1038/sj.bjc.6602479. View

11.

Pavitra E, Dariya B, Srivani G, Kang S, Alam A, Sudhir P . Engineered nanoparticles for imaging and drug delivery in colorectal cancer. Semin Cancer Biol. 2019; 69:293-306. DOI: 10.1016/j.semcancer.2019.06.017. View

12.

Song W, Shen L, Wang Y, Liu Q, Goodwin T, Li J . Synergistic and low adverse effect cancer immunotherapy by immunogenic chemotherapy and locally expressed PD-L1 trap. Nat Commun. 2018; 9(1):2237. PMC: 5993831. DOI: 10.1038/s41467-018-04605-x. View

13.

Ling L, Ouyang Y, Hu Y . Research trends on nanomaterials in gastric cancer: a bibliometric analysis from 2004 to 2023. J Nanobiotechnology. 2023; 21(1):248. PMC: 10394877. DOI: 10.1186/s12951-023-02033-8. View

14.

ONeal D, Hirsch L, Halas N, Payne J, West J . Photo-thermal tumor ablation in mice using near infrared-absorbing nanoparticles. Cancer Lett. 2004; 209(2):171-6. DOI: 10.1016/j.canlet.2004.02.004. View

15.

Jain A, Jain S, Ganesh N, Barve J, Beg A . Design and development of ligand-appended polysaccharidic nanoparticles for the delivery of oxaliplatin in colorectal cancer. Nanomedicine. 2009; 6(1):179-90. DOI: 10.1016/j.nano.2009.03.002. View

16.

Liu J, Li L, Zhang B, Xu Z . MnO-shelled Doxorubicin/Curcumin nanoformulation for enhanced colorectal cancer chemo-immunotherapy. J Colloid Interface Sci. 2022; 617:315-325. DOI: 10.1016/j.jcis.2022.02.132. View

17.

van Eck N, Waltman L . Citation-based clustering of publications using CitNetExplorer and VOSviewer. Scientometrics. 2017; 111(2):1053-1070. PMC: 5400793. DOI: 10.1007/s11192-017-2300-7. View

18.

Dekker E, Tanis P, Vleugels J, Kasi P, Wallace M . Colorectal cancer. Lancet. 2019; 394(10207):1467-1480. DOI: 10.1016/S0140-6736(19)32319-0. View

19.

Patra J, Das G, Fraceto L, Campos E, Del Pilar Rodriguez-Torres M, Acosta-Torres L . Nano based drug delivery systems: recent developments and future prospects. J Nanobiotechnology. 2018; 16(1):71. PMC: 6145203. DOI: 10.1186/s12951-018-0392-8. View

20.

Xiao B, Si X, Han M, Viennois E, Zhang M, Merlin D . Co-delivery of camptothecin and curcumin by cationic polymeric nanoparticles for synergistic colon cancer combination chemotherapy. J Mater Chem B. 2015; 3(39):7724-7733. PMC: 4662402. DOI: 10.1039/c5tb01245g. View